The metabolic effects of APOL1 in humans.

Abstract excerpt

Harboring apolipoprotein L1 (APOL1) variants coded by the G1 or G2 alleles of the APOL1 gene increases the risk for collapsing glomerulopathy, focal segmental glomerulosclerosis, albuminuria, chronic kidney disease, and accelerated kidney function decline towards end-stage kidney disease. However, most subjects carrying APOL1 variants do not develop the kidney phenotype unless a second clinical condition adds to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Apolipoprotein L1
• Share to Chronic Lymphocytic Leukemia Research